Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imiquimod Cream 3.75% vs Zyclara in Actinic Keratosis
NCT01686152Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Sep 2012
- Primary completion
- Aug 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of imiquimod in actinic keratosis (AK), sponsored by Teva Pharmaceutical Industries Ltd.. Started Sep 2012; status: completed.
02
Drugs
imiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01686152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01686152.